Month: July 2025

Introduction and Objective: Neutral sphingomyelinase 2 (nSMase2) is a crucial enzyme involved in several important cellular processes, including exosome formation, ceramide production, cellular stress responses, and inflammatory signaling responses. However, impacts on beta cell health are unknown.Methods: INS-1 823/13 nSMase2 knockdown cells were generated by transfecting plasmids with rat nSMase2 shRNA containing a GFP reporter. […]

Introduction and Objective: Automated insulin delivery (AID) systems provide enhanced glycemic benefits and reduce diabetes care burden. We implemented a QI initiative aimed at increasing AID use in youth with new-onset T1D (<1 yr) at a large pediatric diabetes center from baseline of 5% in Jan 2022 to >25% by Nov 2024. As a balancing […]

Introduction and Objective: Islet transplantation is a promising therapeutic approach for people with unstable T1DM. The main challenge is to reduce the number of pancreases needed to treat a single person. In this context, we have recently demonstrated that ILV-001, a component of the muscle secretome, enables rapid uptake and lasting function of the graft. […]

Introduction and Objective: While the Veterans Affairs (VA) MOVE! Program (DPP-like lifestyle intervention) demonstrated a 24% relative risk reduction in type 2 diabetes (T2D) over 15 years, individual responses varied substantially. We examined this heterogeneity of effects.Methods: Using 2005-2024 VA electronic health records data, we identified NDPP-eligible veterans who enrolled in MOVE! from 2005 to […]

Introduction and Objective: While continuous glucose monitoring (CGM) can enhance diabetes (DM) management, its impact on outpatient, high-cost complications is understudied, particularly in community health centers (CHCs).Methods: Using electronic health record data from a national CHC network, we examined demographic characteristics, care utilization (number of visits and telehealth use), CGM use, and outpatient acute DM […]

Introduction and Objective: With the approval of teplizumab for stage 2 type 1 diabetes (T1D), widespread islet autoantibody (IA) screening is increasingly important. We estimated the size of groups at higher risk for T1D and projected IA positivity rates within the UCSF electronic medical record (EMR).Methods: Using de-identified EMR data, we identified patients of all […]

Introduction and Objective: Treatment with SGLT-2i reduces the risk of both cardiovascular and renal outcomes in type 2 diabetes (T2D). Recent findings indicate that in obese individuals, the kidney exhibits lower 18Fluorodeoxyglucose ([18F]-FDG) uptake rates compared to lean individuals, possibly due to insulin resistance. This study aims to evaluate changes in renal [18F]-FDG uptake in […]

Introduction and Objective: This study analyzes trends in Type 1 diabetes mellitus (T1DM) incidence, prevalence, mortality, and disability-adjusted life years (DALYs) in China from 1990 to 2021, with projections through 2036.Methods: Data from the GBD 2021 study were used to calculate annual changes in age-standardized rates (ASRs) for T1DM via joinpoint regression. Age-period-cohort analysis assessed […]

Introduction and Objective: Glycemic variability (GV) is associated with poor glycemic control and complications in patients with T2DM. The coefficient of variation (CV) derived from CGM has been widely used as a reliable measure of GV.Methods: A total of 773 patients with T2DM were included. A multivariate linear regression model was used to assess independent […]

Introduction and Objective: DKA at the time of first presentation of T1DM is preventable. The aim of this study was to determine the proportion of individuals with a new onset T1DM, by race and ethnicity, presenting with DKA in a large integrated healthcare system based in Northern California (Sutter Health).Methods: ICD-9 and ICD-10 codes were […]